Angelini Pharma to take over Arvelle Therapeutics
Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1247 entries already.
Entries by Thomas Gabrielczyk
COVID-19 test gives results within minutes
/in News/by Thomas GabrielczykUniversity of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results.
EMA greenlights BioNtech’s COVID-19 vaccine
/in News/by Thomas GabrielczykFollowing a rapid FDA approval, the European drug authority EMA has recommended to conditionally approve BioNTechs mRNA vaccine BNT162b2 in the EU.
European Circular Bioeconomy Fund growing
/in News/by Thomas GabrielczykOnly two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.
Novo Holdings creates Hemab
/in News/by Thomas GabrielczykDanish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.
Biotech companies launch Biotech Austria
/in News/by Thomas GabrielczykAustria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.
How microplastic particles get into the body
/in News/by Thomas GabrielczykWeathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.
Centogene and Anylam launch clinical programme
/in News/by Thomas GabrielczykDiagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis.
Avantium NV bags money for demo plant
/in News/by Thomas GabrielczykGreen chemistry company Avantium NV has secured a 7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant.
How stress brings cancer to life again
/in News/by Thomas GabrielczykStress hormones such as cortisol or norephidrine can reawaken dormant tumour cells, a research team led by AstraZeneca has found out.